Denali Therapeutics Inc.
DNLI | NASDAQ
$21.06
+$0.59 (+2.88%)
Sep 22, 2026, 10:29 AM ET · Market open
TTM Period Ending | Q2 2026 Jun 29, 2026 | Q1 2026 Mar 30, 2026 | Q4 2025 Dec 30, 2025 | Q3 2025 Sep 29, 2025 | Q2 2025 Jun 29, 2025 | Q1 2025 Mar 30, 2025 | Q4 2024 Dec 30, 2024 | Q3 2024 Sep 29, 2024 | Q2 2024 Jun 29, 2024 | Q1 2024 Mar 30, 2024 | Q4 2023 Dec 30, 2023 | Q3 2023 Sep 29, 2023 | Q2 2023 Jun 29, 2023 | Q1 2023 Mar 30, 2023 | Q4 2022 Dec 30, 2022 | Q3 2022 Sep 29, 2022 | Q2 2022 Jun 29, 2022 | Q1 2022 Mar 30, 2022 | Q4 2021 Dec 30, 2021 | Q3 2021 Sep 29, 2021 | Q2 2021 Jun 29, 2021 | Q1 2021 Mar 30, 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue | 3.6M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 1.27M | 295.39M | 330.53M | 340.81M | 343.11M | 101.46M | 108.46M | 110.69M | 112.42M | 82.88M | 48.66M | 352.96M | 357.07M | 339.98M |
Cost of Revenue | 5.71M | 5.71M | 2.87M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Gross Profit | -5.71M | -5.71M | -2.87M | n/a | n/a | n/a | n/a | n/a | 1.27M | 295.39M | 330.53M | 340.81M | 343.11M | 101.46M | 108.46M | 110.69M | 112.42M | 82.88M | 48.66M | 352.96M | 357.07M | 339.98M |
Operating Income | -542.7M | -547.12M | -555.34M | -547.82M | -533.58M | -515.21M | -487.34M | -490.07M | -480.68M | -193.6M | -196.7M | -169.47M | -163.16M | -395.06M | -340.74M | -312.52M | -290.63M | -291.03M | -295.75M | 25.45M | 50.93M | 51.47M |
Interest Income | 28.36M | 39.2M | 42.9M | 49.15M | 54.61M | 61.33M | 64.64M | 62.6M | 61.05M | 56.38M | 51.51M | 45.04M | 34.78M | 24.53M | 14.77M | 9.4M | 6.22M | 4.69M | 4.6M | 4.94M | 5.88M | 7.35M |
Pretax Income | -511.35M | -507.92M | -512.44M | -498.68M | -478.97M | -453.87M | -422.71M | -427.46M | -419.62M | -137.22M | -145.19M | -124.44M | -128.38M | -370.53M | -325.97M | -303.12M | -284.41M | -286.34M | -291.16M | 30.39M | 56.8M | 58.82M |
Net Income | -511.45M | -508.02M | -512.54M | -498.74M | -479.03M | -453.94M | -422.77M | -427.49M | -419.65M | -137.25M | -145.22M | -124.43M | -128.38M | -370.55M | -325.99M | -302.57M | -283.86M | -285.76M | -290.58M | 29.57M | 55.93M | 57.86M |
Selling & General & Admin | 139.03M | 135.01M | 133.7M | 127.16M | 116.63M | 109.56M | 105.44M | 100.15M | 100.52M | 101.45M | 103.35M | 102.1M | 100.04M | 95.07M | 90.48M | 88.72M | 84.78M | 82.66M | 79.06M | 75.29M | 71.78M | 66.71M |
Research & Development | 400.72M | 406.4M | 418.78M | 420.66M | 416.95M | 405.65M | 396.44M | 404.46M | 395.96M | 402.08M | 423.88M | 408.18M | 406.23M | 401.45M | 358.73M | 334.5M | 318.27M | 291.24M | 265.35M | 252.22M | 234.37M | 221.81M |
Other Expenses | 843K | n/a | n/a | n/a | n/a | n/a | -14.54M | -14.54M | -14.54M | -14.54M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Operating Expenses | 540.59M | 541.41M | 552.48M | 547.82M | 533.58M | 515.21M | 487.34M | 490.07M | 481.94M | 488.99M | 527.23M | 510.29M | 506.27M | 496.52M | 449.21M | 423.22M | 403.05M | 373.91M | 344.41M | 327.51M | 306.15M | 288.51M |
Interest Expense | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Selling & Marketing Expenses | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost & Expenses | 412.16M | 547.12M | 555.34M | 547.82M | 533.58M | 515.21M | 487.34M | 490.07M | 481.94M | 488.99M | 527.23M | 510.29M | 506.27M | 496.52M | 449.21M | 423.22M | 403.05M | 373.91M | 344.41M | 327.51M | 306.15M | 288.51M |
Income Tax Expense | 102K | 102K | 102K | 68K | 68K | 68K | 68K | 30K | 30K | 30K | 30K | -6K | -6K | 21K | 21K | -548K | -548K | -575K | -575K | 823K | 879K | 958K |
Shares Outstanding (Basic) | 187.31M | 186.64M | 175.46M | 172.42M | 171.45M | 171.22M | 170.09M | 169.46M | 168.83M | 149.4M | 138.25M | 137.64M | 137.05M | 136.52M | 132.88M | 123.47M | 122.49M | 122.67M | 122.16M | 121.74M | 121.29M | 120.76M |
Shares Outstanding (Diluted) | 187.31M | 186.64M | 175.46M | 172.42M | 171.45M | 171.22M | 170.09M | 169.46M | 168.83M | 149.4M | 138.25M | 137.64M | 140.93M | 136.52M | 132.88M | 123.47M | 123.01M | 122.67M | 122.16M | 121.74M | 123.01M | 120.88M |
EPS (Basic) | -2.84 | -2.88 | -2.97 | -2.91 | -2.80 | -2.67 | -2.57 | -2.76 | -2.85 | -0.92 | -1.04 | -0.92 | -1.04 | -2.86 | -2.58 | -2.46 | -2.31 | -2.33 | -2.39 | 0.27 | 0.42 | 0.36 |
EPS (Diluted) | -2.84 | -2.88 | -2.97 | -2.91 | -2.80 | -2.67 | -2.57 | -2.76 | -2.85 | -0.96 | -1.08 | -0.96 | -1.08 | -2.86 | -2.58 | -2.46 | -2.31 | -2.32 | -2.38 | 0.15 | 0.30 | 0.23 |
EBITDA | -503.85M | -493.47M | -497.63M | -485.03M | -466.91M | -443.83M | -444.16M | -449.36M | -441.58M | -158.82M | -128.47M | -105.8M | -109.82M | -352.18M | -315.59M | -294.74M | -275.98M | -277.77M | -283.74M | 36.2M | 60.64M | 60M |
EBIT | -383.8M | -507.92M | -512.44M | -498.68M | -478.97M | -453.87M | -453.16M | -457.91M | -450.07M | -167.67M | -145.19M | -124.44M | -128.38M | -370.53M | -325.97M | -303.12M | -284.41M | -286.34M | -292.34M | 27.58M | 52.05M | 51.47M |
Depreciation & Amortization | 10.49M | 14.45M | 14.81M | 13.65M | 12.06M | 10.04M | 8.99M | 8.55M | 8.5M | 8.84M | 16.73M | 18.64M | 18.56M | 18.35M | 10.38M | 8.39M | 8.43M | 8.56M | 8.59M | 8.62M | 8.59M | 8.53M |
Add to Watchlist
Select watchlists to add or remove DNLI